Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LEONARD H CALABRESE

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1467415265
CMS profile
65714
Location
CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$316,455.15

245 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $94,571.24 62
AstraZeneca Pharmaceuticals LP $78,071.94 62
Amgen Inc. $72,274.89 74
UCB, Inc. $22,418.45 15
GlaxoSmithKline, LLC. $20,212.50 3
Janssen Scientific Affairs, LLC $11,089.22 10
Gilead Sciences, Inc. $6,942.54 10
Regeneron Pharmaceuticals, Inc. $4,850.00 5
E.R. Squibb & Sons, L.L.C. $3,250.00 1
Roche Products Limited $1,387.50 1
Janssen Biotech, Inc. $1,375.00 1
Horizon Therapeutics plc $11.87 1

Page 3 of 5; records 101–150 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LEONARD H CALABRESE

NPI 1467415265 · CMS profile ID 65714

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467415265?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467415265?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467415265?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LEONARD H CALABRESE, NPI 1467415265, CMS profile ID 65714, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1467415265?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

245 matching records · $316,455.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 245 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 245.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $282.7408/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771705 CMS
Amgen Inc. $359.3808/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771707 CMS
Amgen Inc. $20.0008/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771709 CMS
Amgen Inc. $13.0008/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771711 CMS
Janssen Biotech, Inc. $1,375.0008/09/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886348409 CMS
Amgen Inc. $1,100.0008/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771703 CMS
GENZYME CORPORATION $4,212.0007/22/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754981 CMS
AstraZeneca Pharmaceuticals LP $2,150.0007/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914842995 CMS
AstraZeneca Pharmaceuticals LP $4,300.0007/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915250307 CMS
UCB, Inc. $1,500.0007/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965203799 CMS
Amgen Inc. $28.0807/19/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771697 CMS
Amgen Inc. $65.0007/19/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771699 CMS
Amgen Inc. $38.0007/19/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771701 CMS
GlaxoSmithKline, LLC. $14,712.5007/15/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945044089 CMS
Amgen Inc. $26.8807/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771691 CMS
Amgen Inc. $118.0607/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771693 CMS
Amgen Inc. $283.1307/14/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771695 CMS
Amgen Inc. $2,200.0007/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771685 CMS
Amgen Inc. $4,400.0007/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771687 CMS
Amgen Inc. $3,300.0007/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771689 CMS
Amgen Inc. $4,400.0007/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771785 CMS
AstraZeneca Pharmaceuticals LP $3,759.0007/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915533085 CMS
GENZYME CORPORATION $19.8307/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754831 CMS
GENZYME CORPORATION $121.9007/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754939 CMS
GENZYME CORPORATION $3,050.0007/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754941 CMS
GENZYME CORPORATION $248.1707/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754943 CMS
GENZYME CORPORATION $635.2707/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754945 CMS
GENZYME CORPORATION $21.6807/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754821 CMS
GENZYME CORPORATION $3,050.0007/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754933 CMS
GENZYME CORPORATION $248.2507/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754935 CMS
GENZYME CORPORATION $639.7907/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754937 CMS
UCB, Inc. $1,150.0007/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965203797 CMS
GENZYME CORPORATION $119.5907/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754949 CMS
GENZYME CORPORATION $6,710.0007/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754951 CMS
GENZYME CORPORATION $345.1707/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754953 CMS
GENZYME CORPORATION $635.1907/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754955 CMS
GENZYME CORPORATION $810.0007/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938754957 CMS
UCB, Inc. $1,150.0006/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965204459 CMS
Amgen Inc. $1,100.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771683 CMS
AstraZeneca Pharmaceuticals LP $3,750.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914844963 CMS
AstraZeneca Pharmaceuticals LP $758.1806/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914874549 CMS
AstraZeneca Pharmaceuticals LP $4,300.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915144815 CMS
AstraZeneca Pharmaceuticals LP $64.2506/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915321627 CMS
AstraZeneca Pharmaceuticals LP $394.0106/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915414163 CMS
UCB, Inc. $2,012.5006/28/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038610739 CMS
AstraZeneca Pharmaceuticals LP $80.4606/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915671595 CMS
Amgen Inc. $34.7006/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771679 CMS
Amgen Inc. $548.6806/24/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771681 CMS
Amgen Inc. $452.0606/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771671 CMS
Amgen Inc. $775.5806/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933771673 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $335,502.75 286
PY2020 $244,707.50 150
PY2021 $210,188.31 147
PY2022 $316,455.15 245
PY2023 $250,872.06 185
PY2024 $259,438.50 184
PY2025 $294,074.30 214

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,200.00 1
PY2024 Recipient $3,300.00 1
PY2021 Recipient $3,000.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Amgen Inc. $2,200.00 10/15/2025 Covered Recipient Physician A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjgrens Syndrome No dispute reported 06/30/2026 1246637002